CD274 and neoplasm: When human dermal lymphatic endothelial cells (HDLECs) are treated with exosomes, the expression of PD-L1 in HDLECs is increased, exhibiting a tumour-associated phenotype of lymphatic endothelial cells, thereby suppressing tumour immunity.